SCHEMBL15630643

SCHEMBL15630643

c1ccc2c(c1)oc1ccc(-n3c4ccc(-c5ccc6c(c5)c5cc(-c7cccc8c7oc7ccccc78)ccc5n6-c5ccc6oc7ccccc7c6c5)cc4c4cc(-c5cccc6c5oc5ccccc56)ccc43)cc12

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 2/20 0.52
PRKDC P78527 5/20 0.42
GGPS1 O95749 1/20 0.40
PTGES2 Q9H7Z7 1/20 0.38
PRMT5 O14744 1/20 0.37
WDR77 Q9BQA1 1/20 0.37
NPC1 O15118 2/20 0.36
MAPT P10636 2/20 0.36
KDM4E B2RXH2 1/20 0.36
MEN1 O00255 1/20 0.36
ALDH1A1 P00352 1/20 0.36
HPGD P15428 1/20 0.36
RAB9A P51151 1/20 0.36
KMT2A Q03164 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
HSP90AA1 P07900 1/20 0.36
HSP90AB1 P08238 1/20 0.36
ATM Q13315 1/20 0.35
PLA2G2A P14555 2/20 0.34
PLA2G4A P47712 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16639225 0.99 ALOX5 (0.53) ALOX5PRKDCGGPS1PTGES2PRMT5
SCHEMBL20715118 0.96 ALOX5 (0.51) ALOX5PRKDCGGPS1PTGES2PRMT5
SCHEMBL17248353 0.96 ALOX5 (0.51) ALOX5PRKDCGGPS1PTGES2PRMT5
SCHEMBL17885403 0.95 ALOX5 (0.48) ALOX5PRKDCGGPS1PTGES2PRMT5
SCHEMBL22672208 0.94 ALOX5 (0.47) ALOX5PRKDCGGPS1PTGES2PRMT5
SCHEMBL18266066 0.94 ALOX5 (0.47) ALOX5PRKDCGGPS1PTGES2PRMT5
SCHEMBL12158853 0.94 ALOX5 (0.46) ALOX5PRKDCGGPS1PTGES2PRMT5
SCHEMBL21946606 0.94 ALOX5 (0.53) ALOX5PRKDCGGPS1PTGES2PRMT5
SCHEMBL17885360 0.94 ALOX5 (0.50) ALOX5PRKDCGGPS1PTGES2PRMT5
SCHEMBL22107631 0.94 ALOX5 (0.53) ALOX5PRKDCGGPS1PTGES2PRMT5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9842998-B2 Compound, and light emitting diode and electronic apparatus comprising same LMS CO., LTD. (KR) 2017-12-12 US disclosed
US-9842998-B2 Compound, and light emitting diode and electronic apparatus comprising same LMS CO., LTD. (KR) 2017-12-12 US disclosed
US-20160072074-A1 Novel Compound, and Light Emitting Diode and Electronic Apparatus Comprising Same LMS CO., LTD. (KR) 2016-03-10 US disclosed
US-20160072074-A1 Novel Compound, and Light Emitting Diode and Electronic Apparatus Comprising Same LMS CO., LTD. (KR) 2016-03-10 US disclosed
WO-2014046494-A1 NOVEL COMPOUND, AND LIGHT EMITTING DIODE AND ELECTRONIC APPARATUS COMPRISING SAME 주식회사 엘엠에스 (KR) 2014-03-27 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160072074-A1 Novel Compound, and Light Emitting Diode and Electronic Apparatus Comprising Same CRY1, ALDH1A2, CRY2 ALOX5 998/4885PRKDC 4594/4885GGPS1 62/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.